Cargando…

Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States

BACKGROUND: Resection is the cornerstone of curative treatment for many nonmetastatic gastric cancers (GCs), but the population treatment patterns remains largely unknown. This large international population‐based study aimed at investigating the treatment patterns and trends for nonmetastatic GC in...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lei, Jansen, Lina, Balavarca, Yesilda, Verhoeven, Rob H.A., Ruurda, Jelle P., Van Eycken, Liesbet, De Schutter, Harlinde, Johansson, Jan, Lindblad, Mats, Johannesen, Tom B., Zadnik, Vesna, Žagar, Tina, Mägi, Margit, Bastiaannet, Esther, Lagarde, Sjoerd M., van de Velde, Cornelis J.H., Schrotz‐King, Petra, Brenner, Hermann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586997/
https://www.ncbi.nlm.nih.gov/pubmed/33135354
http://dx.doi.org/10.1002/ctm2.203
_version_ 1783600102729842688
author Huang, Lei
Jansen, Lina
Balavarca, Yesilda
Verhoeven, Rob H.A.
Ruurda, Jelle P.
Van Eycken, Liesbet
De Schutter, Harlinde
Johansson, Jan
Lindblad, Mats
Johannesen, Tom B.
Zadnik, Vesna
Žagar, Tina
Mägi, Margit
Bastiaannet, Esther
Lagarde, Sjoerd M.
van de Velde, Cornelis J.H.
Schrotz‐King, Petra
Brenner, Hermann
author_facet Huang, Lei
Jansen, Lina
Balavarca, Yesilda
Verhoeven, Rob H.A.
Ruurda, Jelle P.
Van Eycken, Liesbet
De Schutter, Harlinde
Johansson, Jan
Lindblad, Mats
Johannesen, Tom B.
Zadnik, Vesna
Žagar, Tina
Mägi, Margit
Bastiaannet, Esther
Lagarde, Sjoerd M.
van de Velde, Cornelis J.H.
Schrotz‐King, Petra
Brenner, Hermann
author_sort Huang, Lei
collection PubMed
description BACKGROUND: Resection is the cornerstone of curative treatment for many nonmetastatic gastric cancers (GCs), but the population treatment patterns remains largely unknown. This large international population‐based study aimed at investigating the treatment patterns and trends for nonmetastatic GC in Europe and the United States and at exploring factors associated with resection. METHODS: Data of patients with microscopically confirmed primary invasive GC without distant metastasis from the national cancer registries of the Netherlands, Belgium, Sweden, Norway, Slovenia, and Estonia and the US Surveillance, Epidemiology, and End Results (SEER)‐18 Program were retrieved. Age‐standardized treatment rates were computed and trends were evaluated using linear regression. Associations of resection with patient and tumor characteristics were analyzed using multivariable‐adjusted log‐binomial regression. Analysis was performed in each country respectively without pooling. RESULTS: Together 65 707 nonmetastatic GC patients diagnosed in 2003‐2016 were analyzed. Age‐standardized resection rates significantly decreased over years in all countries (by 4‐24%). In 2013‐2014, rates varied greatly from 54 to 75%. Patients with increasing ages, cardia cancers, or cancers invading adjacent structure were significantly less frequently resected. Resection was further associated with sex, performance status, comorbidities, tumor histology, tumor size, hospital type, and hospital volume. Association patterns and strengths varied across countries. After multivariable adjustment, resection rates remained decreasing (prevalence ratio = 0.97‐0.995 per year), with decreasing trends consistently seen in various subgroups. CONCLUSIONS: In Europe and the United States, nonmetastatic gastric cancers were less frequently resected in the early 21st century. Resection rates varied greatly across countries and appeared not optimal. Various factors associated with resection were revealed. Our findings identify differences and possibly modifiable places in clinical practice and provide important novel references for designing effective population‐based management strategies.
format Online
Article
Text
id pubmed-7586997
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75869972020-10-30 Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States Huang, Lei Jansen, Lina Balavarca, Yesilda Verhoeven, Rob H.A. Ruurda, Jelle P. Van Eycken, Liesbet De Schutter, Harlinde Johansson, Jan Lindblad, Mats Johannesen, Tom B. Zadnik, Vesna Žagar, Tina Mägi, Margit Bastiaannet, Esther Lagarde, Sjoerd M. van de Velde, Cornelis J.H. Schrotz‐King, Petra Brenner, Hermann Clin Transl Med Research Articles BACKGROUND: Resection is the cornerstone of curative treatment for many nonmetastatic gastric cancers (GCs), but the population treatment patterns remains largely unknown. This large international population‐based study aimed at investigating the treatment patterns and trends for nonmetastatic GC in Europe and the United States and at exploring factors associated with resection. METHODS: Data of patients with microscopically confirmed primary invasive GC without distant metastasis from the national cancer registries of the Netherlands, Belgium, Sweden, Norway, Slovenia, and Estonia and the US Surveillance, Epidemiology, and End Results (SEER)‐18 Program were retrieved. Age‐standardized treatment rates were computed and trends were evaluated using linear regression. Associations of resection with patient and tumor characteristics were analyzed using multivariable‐adjusted log‐binomial regression. Analysis was performed in each country respectively without pooling. RESULTS: Together 65 707 nonmetastatic GC patients diagnosed in 2003‐2016 were analyzed. Age‐standardized resection rates significantly decreased over years in all countries (by 4‐24%). In 2013‐2014, rates varied greatly from 54 to 75%. Patients with increasing ages, cardia cancers, or cancers invading adjacent structure were significantly less frequently resected. Resection was further associated with sex, performance status, comorbidities, tumor histology, tumor size, hospital type, and hospital volume. Association patterns and strengths varied across countries. After multivariable adjustment, resection rates remained decreasing (prevalence ratio = 0.97‐0.995 per year), with decreasing trends consistently seen in various subgroups. CONCLUSIONS: In Europe and the United States, nonmetastatic gastric cancers were less frequently resected in the early 21st century. Resection rates varied greatly across countries and appeared not optimal. Various factors associated with resection were revealed. Our findings identify differences and possibly modifiable places in clinical practice and provide important novel references for designing effective population‐based management strategies. John Wiley and Sons Inc. 2020-10-08 /pmc/articles/PMC7586997/ /pubmed/33135354 http://dx.doi.org/10.1002/ctm2.203 Text en © 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Huang, Lei
Jansen, Lina
Balavarca, Yesilda
Verhoeven, Rob H.A.
Ruurda, Jelle P.
Van Eycken, Liesbet
De Schutter, Harlinde
Johansson, Jan
Lindblad, Mats
Johannesen, Tom B.
Zadnik, Vesna
Žagar, Tina
Mägi, Margit
Bastiaannet, Esther
Lagarde, Sjoerd M.
van de Velde, Cornelis J.H.
Schrotz‐King, Petra
Brenner, Hermann
Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States
title Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States
title_full Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States
title_fullStr Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States
title_full_unstemmed Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States
title_short Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States
title_sort decreasing resection rates for nonmetastatic gastric cancer in europe and the united states
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586997/
https://www.ncbi.nlm.nih.gov/pubmed/33135354
http://dx.doi.org/10.1002/ctm2.203
work_keys_str_mv AT huanglei decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT jansenlina decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT balavarcayesilda decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT verhoevenrobha decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT ruurdajellep decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT vaneyckenliesbet decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT deschutterharlinde decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT johanssonjan decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT lindbladmats decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT johannesentomb decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT zadnikvesna decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT zagartina decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT magimargit decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT bastiaannetesther decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT lagardesjoerdm decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT vandeveldecornelisjh decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT schrotzkingpetra decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates
AT brennerhermann decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates